|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schiller JH, Gandara DR, Goss GD and Vokes
EE: Non-small-cell lung cancer: Then and now. J Clin Oncol.
31:981–983. 2013.doi: 10.1200/JCO.2012.47.5772. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tymms MJ, Ng AY, Thomas RS, Schutte BC,
Zhou J, Eyre HJ, Sutherland GR, Seth A, Rosenberg M, Papas T, et
al: A novel epithelial-expressed ETS gene, ELF3: Human and murine
cDNA sequences, murine genomic organization, human mapping to
1q32.2 and expression in tissues and cancer. Oncogene.
15:2449–2462. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Choi SG, Yi Y, Kim YS, Kato M, Chang J,
Chung HW, Hahm KB, Yang HK, Rhee HH, Bang YJ and Kim SJ: A novel
ets-related transcription factor, ERT/ESX/ESE-1, regulates
expression of the transforming growth factor-β type II receptor. J
Biol Chem. 273:110–117. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chang CH, Scott GK, Kuo WL, Xiong X,
Suzdaltseva Y, Park JW, Sayre P, Erny K, Collins C, Gray JW, et al:
: ESX: A structurally unique Ets overexpressed early during human
breast tumorigenesis. Oncogene. 14:1617–1622. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Oettgen P, Finger E, Sun Z, Akbarali Y,
Thamrongsak U, Boltax J, Grall F, Dube A, Weiss A, Brown L, et al:
PDEF, a novel prostate epithelium-specific ets transcription
factor, interacts with the androgen receptor and activates
prostate-specific antigen gene expression. J Biol Chem.
275:1216–1225. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Oettgen P, Alani RM, Barcinski MA, Brown
L, Akbarali Y, Boltax J, Kunsch C, Munger K and Libermann TA:
Isolation and characterization of a novel epithelium-specific
transcription factor, ESE-1, a member of the ets family. Mol Cell
Biol. 17:4419–4433. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brembeck FH, Opitz OG, Libermann TA and
Rustgi AK: Dual function of the epithelial specific ets
transcription factor, ELF3, in modulating differentiation.
Oncogene. 19:1941–1949. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang JL, Chen ZF, Chen HM, Wang MY, Kong
X, Wang YC, Sun TT, Hong J, Zou W, Xu J, et al: Elf3 drives
β-catenin transactivation and associates with poor prognosis in
colorectal cancer. Cell Death Dis. 5:e12632014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yeung TL, Leung CS, Wong KK,
Gutierrez-Hartmann A, Kwong J, Gershenson DM and Mok SC: ELF3 is a
negative regulator of epithelial-mesenchymal transition in ovarian
cancer cells. Oncotarget. 8:16951–16963. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Iwai S, Amekawa S, Yomogida K, Sumi T,
Nakazawa M, Yura Y, Nishimune Y and Nozaki M: ESE-1 inhibits the
invasion of oral squamous cell carcinoma in conjunction with MMP-9
suppression. Oral Dis. 14:144–149. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee SH, Bahn JH, Choi CK, Whitlock NC,
English AE, Safe S and Baek SJ: ESE-1/EGR-1 pathway plays a role in
tolfenamic acid-induced apoptosis in colorectal cancer cells. Mol
Cancer Ther. 7:3739–3750. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Longoni N, Sarti M, Albino D, Civenni G,
Malek A, Ortelli E, Pinton S, Mello-Grand M, Ostano P, D'Ambrosio
G, et al: ETS transcription factor ESE1/ELF3 orchestrates a
positive feedback loop that constitutively activates NF-kappaB and
drives prostate cancer progression. Cancer Res. 73:4533–4547. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shatnawi A, Norris JD, Chaveroux C, Jasper
JS, Sherk AB, McDonnell DP and Giguère V: ELF3 is a repressor of
androgen receptor action in prostate cancer cells. Oncogene.
33:862–871. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Oliver JR, Kushwah R, Wu J, Pan J, Cutz E,
Yeger H, Waddell TK and Hu J: Elf3 plays a role in regulating
bronchiolar epithelial repair kinetics following Clara
cell-specific injury. Lab Invest. 91:1514–1529. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee SH, Bahn JH, Whitlock NC and Baek SJ:
Activating transcription factor 2 (ATF2) controls tolfenamic
acid-induced ATF3 expression via MAP kinase pathways. Oncogene.
29:5182–5192. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee SH, Cekanova M and Baek SJ: Multiple
mechanisms are involved in 6-gingerol-induced cell growth arrest
and apoptosis in human colorectal cancer cells. Mol Carcinog.
47:197–208. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ng AY, Waring P, Ristevski S, Wang C,
Wilson T, Pritchard M, Hertzog P and Kola I: Inactivation of the
transcription factor Elf3 in mice results in dysmorphogenesis and
altered differentiation of intestinal epithelium. Gastroenterology.
122:1455–1466. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang H, Yu Z, Huo S, Chen Z, Ou Z, Mai J,
Ding S and Zhang J: Overexpression of ELF3 facilitates cell growth
and metastasis through PI3K/Akt and ERK signaling pathways in
non-small cell lung cancer. Int J Biochem Cell Biol. 94:98–106.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang X and Lee SH: Identification of ESE1
as a β-Catenin Binding Protein. Anticancer Res. 36:2697–2703.
2016.PubMed/NCBI
|
|
21
|
Singla AK, Downey CM, Bebb GD and Jirik
FR: Characterization of a murine model of metastatic human
non-small cell lung cancer and effect of CXCR4 inhibition on the
growth of metastases. Oncoscience. 2:263–271. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Derynck R and Zhang YE: Smad-dependent and
Smad-independent pathways in TGF-beta family signalling. Nature.
425:577–584. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang YE: Non-Smad pathways in TGF-beta
signaling. Cell Res. 19:128–139. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sinh ND, Endo K, Miyazawa K and Saitoh M:
Ets1 and ESE1 reciprocally regulate expression of ZEB1/ZEB2,
dependent on ERK1/2 activity, in breast cancer cells. Cancer Sci.
108:952–960. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chang J, Lee C, Hahm KB, Yi Y, Choi SG and
Kim SJ: Over-expression of ERT(ESX/ESE-1/ELF3), an ets-related
transcription factor, induces endogenous TGF-beta type II receptor
expression and restores the TGF-beta signaling pathway in Hs578t
human breast cancer cells. Oncogene. 19:151–154. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Park SW, Do HJ, Ha WT, Han MH, Yang HM,
Lee SH, Song H, Kim NH and Kim JH: Transcriptional regulation of
OCT4 by the ETS transcription factor ESE-1 in NCCIT human embryonic
carcinoma cells. Biochem Biophys Res Commun. 450:984–990. 2014.
View Article : Google Scholar : PubMed/NCBI
|
